VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost

28.05.26 14:07 Uhr

Werte in diesem Artikel
Aktien

1.122,00 JPY 0,00 JPY 0,00%

The Vanguard Health Care ETF (NYSEMKT:VHT) offers broad, low-cost exposure to the full healthcare sector, whereas the State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides a targeted, more volatile bet on biotechnology firms.Both funds serve as primary vehicles for gaining healthcare exposure, yet they employ distinct strategies. Investors may choose between a comprehensive sector-wide approach or a specific sub-industry focus that utilizes a modified equal-weighting methodology to capture the growth potential of smaller biotechnology companies.Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Quelle: MotleyFool

Nachrichten zu Top's Inc. Registered Shs